CompletedPhase 4NCT00161785

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

Studying Encephalitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pfizer
Principal Investigator
Ryszard Konior, MD
Szpital Jana Pawla II Oddzial Neuroinfekcji, Krakow, Poland
Intervention
FSME-IMMUN 0.5ml(biological)
Enrollment
340 enrolled
Eligibility
18-67 years · All sexes
Timeline
2004 – 2005

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00161785 on ClinicalTrials.gov

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Encephalitis →

← Back to all trials